In early 2026, the integration of artificial intelligence with optical coherence tomography (OCT) is allowing nephrologists and ophthalmologists to predict inflammatory "flares" before the patient experiences a loss of vision. These 2026 AI algorithms analyze retinal thickness and the presence of inflammatory cells in the aqueous humor to identify the earliest markers of recurrence. In early...